Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

Arcus Biosciences (NYSE:RCUS) reported positive late stage efficacy results for casdatifan, its investigational HIF-2a inhibitor, in late line renal cell carcinoma. The company released biomarker ...

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when ...

In the final episode, Assessing Long-Term Renal Outcomes and Kidney Failure Risk Reduction in IgA Nephropathy, the panelists explored the following critical questions: What is the impact of therapy on ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

The kidneys play a vital role in determining health and lifespan. Their primary function is to eliminate waste products and surplus fluids from the body via urine. This intricate process of excretion ...

Today, the American Kidney Fund (AKF) is kicking off its seventh annual Kidney Action Week®, the only free, virtual conference in the country that brings together members of the kidney ...

High-protein diets are a frequent topic in clinics, sparking concerns about kidney harm for some and perceived benefits for others. The reality is nuanced, with the source and quantity of protein, as ...

On March 1, the American Kidney Fund (AKF) will kick off Kidney Month by highlighting why Kidneys Count and how people can protect their kidney health. Kidney Month is observed every March and ...